SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001104659-20-083148
Filing Date
2020-07-13
Accepted
2020-07-13 17:28:36
Documents
13

Document Format Files

Seq Description Document Type Size
1 FORM F-3 tm2024433-1_f3.htm F-3 381681
2 EXHIBIT 1.2 tm2024433d1_ex1-2.htm EX-1.2 255815
3 EXHIBIT 4.2 tm2024433d1_ex4-2.htm EX-4.2 307027
4 EXHIBIT 4.3 tm2024433d1_ex4-3.htm EX-4.3 320132
5 EXHIBIT 5.1 tm2024433d1_ex5-1.htm EX-5.1 25768
6 EXHIBIT 5.2 tm2024433d1_ex5-2.htm EX-5.2 17655
7 EXHIBIT 23.1 tm2024433d1_ex23-1.htm EX-23.1 3225
8 GRAPHIC tm2024433-1_f3img001.jpg GRAPHIC 9573
9 GRAPHIC tm2024433-1_f3img002.jpg GRAPHIC 21065
10 GRAPHIC tm204433d1_ex5-1img001.jpg GRAPHIC 17634
11 GRAPHIC tm204433d1_ex5-1img002.jpg GRAPHIC 43736
12 GRAPHIC image_001.jpg GRAPHIC 5980
13 GRAPHIC image_002.jpg GRAPHIC 2381
  Complete submission text file 0001104659-20-083148.txt   1451491
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Filer) CIK: 0001638097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-239843 | Film No.: 201025870
SIC: 2836 Biological Products, (No Diagnostic Substances)